Conservative Treatment of Acute Cholangitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21885

Enrollment

400

Registered

2019-11-11

Start date

2019-11-11

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholangitis, choledocholithiasis

Interventions

None

Eligibility

Inclusion criteria

Inclusion criteria: - First episode acute cholangitis (DBC code)due to choledocholithiasis - Examined patient was 18 years or older at time of diagnosis

Exclusion criteria

Exclusion criteria: - Patients who made an objection to the use of personal data - No acute cholangitis according to definition Dutch Pancreatitis Workgroup - Cholangitis due to etiology other than choledocholithiasis

Design outcomes

Primary

Measure	Time frame
The main study endpoint is the occurrence of readmission during 24 weeks of follow-up.	—

Secondary

Measure	Time frame
1. Total number of biliary events 2. Total number ofERCPs 3. Total number of hospital admissions 4. Days of hospital admission 5. Total number of post-ERCP complications 6. Mortality	—

Contacts

Public ContactDaan Von den Hoff

Radboudumc

daan.vondenhoff@radboudumc.nl+31634244461

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)